A Phase 4 interventional study of Cold snare polypectomy in Peutz-Jeghers Syndrome and Small Bowel Polyp, sponsored by Shandong University. Not yet recruiting at 1 site in China. Open to participants aged 8 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-08-21.
Sponsored by Shandong University · Phase 4, Interventional, and Treatment
This study aims to evaluate the feasibility and safety of Cold snare polypectomy for removing 5-9mm small intestinal polyps in patients with Peutz-Jeghers Syndrome (PJS),in order to provide some reference for clinical strategy of endoscopic treatment of small intestinal polyps in PJS patients, and may prolong the follow-up period of PJS patients Intervals.
22 studies on the registry are indexed under Peutz-Jeghers Syndrome; 8 are open to participants now.
Browse Peutz-Jeghers Syndrome studies →Shandong University is the lead sponsor of 292 studies on the registry; 60 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Cold snare polypectomy
For eligible patients, use cold snare polypectomy to resect 5-9mm short-pedicled, broad-pedicled or sessile small bowel polyps
Incidence of complications in the application of cold snare polypectomy for 5-9mm small bowel polypectomy in patients with PJS
The complications include complications during CSP and complications occurring within 28 days after enteroscopy
Time frame: 28 days after the procedure
Incidence of complications during cold snare polypectomy for 5-9mm small bowel polypectomy
Including intraoperative bleeding (defined as active haemorrhage for more than 30s), perforation immediately, etc.
Time frame: Immediately after the procedure
Incidence of complications within 28 days after enteroscopy
Including Delayed bleeding, delayed perforation, pancreatitis, electrocoagulation syndrome.
Time frame: 28 days after the procedure
Start is estimated for Aug 2023; primary completion for Dec 2024, 16 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.